Association of Timely Comprehensive Genomic Profiling With Precision Oncology Treatment Use and Patient Outcomes in Advanced Non-Small-Cell Lung Cancer.

Jeff YorioKatherine T Lofgren Jessica K Lee Khaled Tolba Geoffrey R Oxnard Alexa B Schrock Richard S P HuangLorraine Brisbin

Published in: JCO precision oncology (2024)

Timely CGP is associated with the quality of patient care as measured by 1L matched targeted therapy use, time to therapy discontinuation, and avoidance of ineffective, costly ICPIs.

Keyphrases

advanced non small cell lung cancer
epidermal growth factor receptor
palliative care
single cell
copy number
gene expression
replacement therapy
cell therapy